United States · FDA National Drug Code directory
Guaifenesin 600 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25000-042_0af3bdb4-c1f3-4941-a1de-6e08c49849cb
- Product NDC
- 25000-042
- Form
- TABLET
- Composition / generic term
- Guaifenesin 600 mg
- Labeler
- MARKSANS PHARMA LIMITED
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230823
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (25000-042-01) / 20 TABLET in 1 BOTTLE · 25000-042-01
- 500 TABLET in 1 BOTTLE (25000-042-12) · 25000-042-12
- 2 BLISTER PACK in 1 CARTON (25000-042-55) / 10 TABLET in 1 BLISTER PACK · 25000-042-55
- 2 BLISTER PACK in 1 CARTON (25000-042-99) / 20 TABLET in 1 BLISTER PACK · 25000-042-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →